Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update

Growing consistent evidence indicates that hypofunction of N-methyl-D-aspartate (NMDA) transmission plays a pivotal role in the neuropathophysiology of schizophrenia. Hence, drugs which modulate NMDA neurotransmission are promising approaches to the treatment of schizophrenia. The aim of this articl...

Full description

Bibliographic Details
Main Authors: C. Chaves, C.R. Marque, C. Trzesniak, J.P. Machado de Sousa, A.W. Zuardi, J.A.S. Crippa, S.M. Dursun, J.E. Hallak
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2009-11-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Schizophrenia
NMDA agonist
Glycine
Glutamate
Clinical trial
Minocycline
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001100002

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009001100002

Similar Items